rs727503869

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP3BP6BS1BS2

The NM_005120.3(MED12):​c.6321_6335delGCAGCAGCAACAGCA​(p.Gln2108_Gln2112del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000819 in 1,157,316 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 258 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. Q2107Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00046 ( 0 hom., 13 hem., cov: 23)
Exomes 𝑓: 0.00086 ( 0 hom. 245 hem. )

Consequence

MED12
NM_005120.3 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 3.01
Variant links:
Genes affected
MED12 (HGNC:11957): (mediator complex subunit 12) The initiation of transcription is controlled in part by a large protein assembly known as the preinitiation complex. A component of this preinitiation complex is a 1.2 MDa protein aggregate called Mediator. This Mediator component binds with a CDK8 subcomplex which contains the protein encoded by this gene, mediator complex subunit 12 (MED12), along with MED13, CDK8 kinase, and cyclin C. The CDK8 subcomplex modulates Mediator-polymerase II interactions and thereby regulates transcription initiation and reinitation rates. The MED12 protein is essential for activating CDK8 kinase. Defects in this gene cause X-linked Opitz-Kaveggia syndrome, also known as FG syndrome, and Lujan-Fryns syndrome. [provided by RefSeq, Aug 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_005120.3
BP6
Variant X-71141271-ACAGCAACAGCAGCAG-A is Benign according to our data. Variant chrX-71141271-ACAGCAACAGCAGCAG-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 166877.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=3}.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00046 (51/110952) while in subpopulation NFE AF = 0.000758 (40/52791). AF 95% confidence interval is 0.000572. There are 0 homozygotes in GnomAd4. There are 13 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position FAILED quality control check.
BS2
High Hemizygotes in GnomAd4 at 13 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MED12NM_005120.3 linkc.6321_6335delGCAGCAGCAACAGCA p.Gln2108_Gln2112del disruptive_inframe_deletion Exon 43 of 45 ENST00000374080.8 NP_005111.2 Q93074-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MED12ENST00000374080.8 linkc.6321_6335delGCAGCAGCAACAGCA p.Gln2108_Gln2112del disruptive_inframe_deletion Exon 43 of 45 1 NM_005120.3 ENSP00000363193.3 Q93074-1

Frequencies

GnomAD3 genomes
AF:
0.000460
AC:
51
AN:
110952
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000263
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000192
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000166
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000758
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000432
AC:
49
AN:
113535
AF XY:
0.000296
show subpopulations
Gnomad AFR exome
AF:
0.000306
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000711
Gnomad NFE exome
AF:
0.000861
Gnomad OTH exome
AF:
0.000306
GnomAD4 exome
AF:
0.000857
AC:
897
AN:
1046364
Hom.:
0
AF XY:
0.000724
AC XY:
245
AN XY:
338476
show subpopulations
Gnomad4 AFR exome
AF:
0.0000808
AC:
2
AN:
24754
Gnomad4 AMR exome
AF:
0.0000717
AC:
2
AN:
27894
Gnomad4 ASJ exome
AF:
0.00
AC:
0
AN:
18579
Gnomad4 EAS exome
AF:
0.00
AC:
0
AN:
27093
Gnomad4 SAS exome
AF:
0.00
AC:
0
AN:
49724
Gnomad4 FIN exome
AF:
0.000531
AC:
20
AN:
37640
Gnomad4 NFE exome
AF:
0.00104
AC:
843
AN:
812552
Gnomad4 Remaining exome
AF:
0.000680
AC:
30
AN:
44091
Heterozygous variant carriers
0
33
66
99
132
165
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000460
AC:
51
AN:
110952
Hom.:
0
Cov.:
23
AF XY:
0.000389
AC XY:
13
AN XY:
33380
show subpopulations
Gnomad4 AFR
AF:
0.000263
AC:
0.000262571
AN:
0.000262571
Gnomad4 AMR
AF:
0.000192
AC:
0.000191773
AN:
0.000191773
Gnomad4 ASJ
AF:
0.00
AC:
0
AN:
0
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 FIN
AF:
0.000166
AC:
0.000165782
AN:
0.000165782
Gnomad4 NFE
AF:
0.000758
AC:
0.000757705
AN:
0.000757705
Gnomad4 OTH
AF:
0.00
AC:
0
AN:
0
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000434
Hom.:
2

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

FG syndrome Uncertain:1
Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant, c.6321_6335del, results in the deletion of 5 amino acid(s) of the MED12 protein (p.Gln2111_Gln2115del), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with MED12-related conditions. ClinVar contains an entry for this variant (Variation ID: 166877). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not specified Benign:1
Dec 18, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Nov 05, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Nov 30, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance -

MED12-related disorder Benign:1
Jul 15, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
Mutation Taster
=183/17
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs727503869; hg19: chrX-70361121; API